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On the Cover:
An inside view of a PET (positron
emi ssion tomograph y) machine.
PET was developed at Washington
University by Michel M. T er
Pogossian, Ph.D., and Cardiovas
cul ar Division scientists and physi
cians have been instrumental in the
development of this technology .
Barnes Hospital is the only hospital
in the country with a PET scarmer in
the Cardiac Care Unit, which allows
evaluation of acutely ill patients.
See story on page 14.
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Newsbriefs
Diabetic off insulin after
36-year-old female
patient who received a
_L ..l .. transplant of insulin
producing cells isolated from
cadaver pancreases was suc
cessfully off insulin injections
for more than two weeks,
Washington University re
searchers have reported in a
recent issue of the journal,
Diabetes.
The patient is one of sever
al who received pancreatic
islet cell transplants through
pilot clinical trials at the
School of Medicine's Clinical
Research Center and Barnes
Hospital. The transplanted
cells are removed from the
pancreas's "islets," pockets of
hormone-producing tissue that
release insulin. Within 10 days
of receiving the new islets, the
patient no longer required dai
ly injections of insulin. The
patient remained insulin-in
dependent until the 25th day
after transplantation, when
evidence of tissue rejection
appeared and the patient
began to require gradually
increasing amounts of supple
mental insulin . At this point
there is no evidence of contin
uing graft function.
This case marks the first
time that transplanting puri
fied , isolated cells has eradi
cated the need for insulin in
jections in a patient with juve
nile-onset diabetes. Research
ers had until now accomplished
only a partial reduction in
patients ' needs for insulin.
"We are immensely pleased
that the grafted tissue was able
to satisfy all of the patient 's
insulin requirements before it
was rejected," said David
Scharp, M.D., the surgeon
who conducted the transplant.
"Our first trials, in 1985, were
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Islet Lab.
designed to determine that
islet transplants were safe. In
this study, our primary goal
was to determine if we could
isolate, purify and transplant
enough islets to bring a patient
completely off of insulin."
Paul Lacy, M.D., Ph .D., the
Washington University pathol
ogist who devised many of the
techniques used to isolate and
purify human islets, said this
patient's case "shows that islet
transplantation is a feasible
approach to controlling insulin
dependent diabetes and clearly
establishes the need to move
on to larger clinical trials . Re
jection, which prevents our
ability to keep the patient off
of insulin long-term, is a totally
separate problem, and our pre
vious research gives us many
good ideas about how to com
bat rejection in future trials."
Scharp added : "While these
results are an important step

forward , many more years of
research may be needed before
islet transplantation can be
come a routine treatment for
diabetics."
The patient reported in
Diabetes received approxi
mately 800,000 islets isolated
from two cadaver pancreases.
The islets were 95 percent
pure, according to the re
searchers, and were tested to
confirm their ability to pro
duce insulin. The patient was
under local anesthesia when
the islets were injected into the
liver. The insulin production of
the transplant was determined
through precise measurements
of C-peptide, a precursory
fragment of the insulin mole
cule that is released from islet
cells along with intact insulin.
In the transplant procedure,
insulin-producing ceHs are
harvested and purified from
one or more cadaver pan

creases, then injected into a
patient's liver. Once estab
lished, the cells act as a natural
source of insulin and reduce or
obviate the need for daily in
jections. These clinical trials
are limited to diabetics with no
insulin production who have
either a previous or simultane
ous kidney transplant and are
immune-suppressed with cyclo
sporin and other medications.
The researchers were hopeful
that the immune suppression
used to maintain the kidney
transplant would also protect
the islets from rejection.
The Washington University
Human Islet Transplantation
Center has agreements with
three universities for expanded
clinical trials in diabetic pa
tients who are to receive a
kidney transplant: University
of Western Ontario at London,
Ontario; University of Florida
at Gainesville; and University
of Pennsylvania in Philadel
phia. Researchers collabor
ating with Lacy and Scharp
will send a pancreas to St.
Louis for islet isolation. The
islets will quickly be returned
and transplanted, along with
the same donor's kidney, into
a patient with juvenile-onset
diabetes. The combined kid
ney/islet transplants will be
conducted according to proto
cols approved by both Wash
ington University and the col
laborating institution.

Note: Just before this issue of Outlook
went to press Lacy and Scharp pre
sented new data on the status of these
pi lot studies and reponed that they
now have a male transp lant recipient
who remains insulin-independent
seven weeks post-transplant. The
status of this patient and all others in
the clinical tria ls was prese nted at the
Annual Meeting of The American
Society of Transplant Surgeons and
will be submitted for publication in
the journal , Transplantation.

Vi('e Chancellor P
I (/organizes adlllin 'stration
iLiiam A. Peck. M.D ..
vice chance ll o r for
medical affa irs and
dea n or the School of Medi
ci ne, has made se ve ra l new
admi nistrat ive appoint ments_
Patr ici a L. C o le , M.D .. has
been nam ed associ ate dean for
stude nt allairs. C o le has been
on the facul ty for four years
and is an ass istant pmfesso r of
me di cine. She is U1C di rector
of invasi ve card iology training
at Je wish H o ~ p l tal. w he re he r
clinical t' l1l p ha s i ~ is cardiac
catheterizat io n and balloon
an g ioplasty_ In her new role
she will be responsib le for
dealing with st ucic n h ' :lca
demic affairs, a ~ s isting th em
with fi na ncial aid, reviewing
clerkship re pon s and su per
vising ope ration of O lin Re si
de nce I Ja il.
W. Edwin Dodson, MD "
has accepte d the pos ition 01
associa te dean lor admi ss ons
and will he re~ po n sible for
planning and manag ing the
aclmi ss ions prog rams a t the
Sc hool of M edicine. D odson
has been with the sc hool since
1971 and for the last four years
has been a professor of pedi 
atrics an d neurology. He is in
volved in the research of
se vere epile psy and its treat
ment an d also has an active
in teres t in the prevention of
child ab use.
The ap poi ntments o j Co le
and D odson beca me effec tive
on July I, w hen 101111 C.
Hc rwe g . M .D .. re tired as
assoc iate de an o r the School
o f Medic ine. S hari ng I-Ie rweg's
responsibi li Lies e nabl es C ole
anc! Dodson [ 0 c ontinue their
researc h :lnd cl inica l ac tiv iti es .
C arl D. Rhodes. Jr. . Ph .D..

T

has been named associate
de an for gradua te studies at
the S chool of M edicine as
welJ as associate dean in the
G raduate Sc hool of A11S and
Sciences. R hodes' primary
responsibility will be to serve
as chief academic adminis
trator for the six interdepart
mental Ph.D . programs in the
D ivi sion of B iology and B io
med ical Sciences. Rhodes ,
who was at Washington Uni
vers ity from 1983 to 1988 and
at the U n i e r~it y of Texas
Sout hwe stern Me dical C enter
from 1988 to July 1990, also
received two faculty appoint
me nts : research professor of
biochemistry and molecu lar
biophysics, and professor of
biolo g y.
Thoma ~ R. Sonderegger
has bcen promoted to assistant
vi ce chancellor and assistant
clean. Sonderegger has been
on the med ical school staff 12
years, the last five as director
of strategic planning, respon
sible for enhancing financial
planning systems. H e has been
responsible for developing
strategies for the allocation of
resources, creating financial
forec a ~ l m odels and partici
pating in long-range planning
efforts. In his new post he will
con tin ue directing that area
and will also develop systems
to study and plan for the ex
pan sion of clinical and re
search faciliti es, to facilitate
depart me ntal financial plan
ning and to coordinate strate
gic plannillg efforts between
the medical school's clinical
de partments and Barn es
I lospital.
Valo rle 1. Hambley has
been named assistant dean for

administration. Her primary
responsibilities in this new
post are research adminis
tration and human resource
management. For the last
seven years, Hambley has
served as administrator for the
De partment of Phannacology,
responsible for handling
grants, personnel, payroll and
finances. She also acted as a
liaison between researchers,
university administration and
outside funding agencies and
for a brief period worked as
interim co-business manager
for th e O ffice of Animal Lab
oratory C are_
Glenda K. Wiman, former
ly the executive director of
medical public affairs, has
been appointed assistant dean
for special programs. In this
newly created position, Wiman
will have a broad range of ac
tivities including coordinating
the National Council of the
School of M edicine, devel
oping continuing education
programs, assisting in the
development of depanment
head, faculty and student
recruitment programs and
initiating new corporate and
community relations efforts.
Wi man has been in the Office
of Medical Public Affairs for
more th an 15 years, serving as
director since 1981 and exec
utive director since 1987.
Donald C layton has been
appointed the new executi ve
director of medical public
affairs. Clayton has worked at
the School of Medicine for
eight years, most recently as
director of medical public re
lations. He will supervise the
media relations, publications
and photographic services.

Hortin re<-ci
Culpeper
Seholalws 1 ,

:It

len Hortin, M.D.,
Ph.D., assistant pro
fessor in pediatrics
and pathology at Washington
University School of Medi
cine in St. Louis, recently
received the Charles E. Cul
peper Foundation Scholarship
in Medical Science for 1990.
With this award, Honin
will receive $100,000 a year

Glell Hortill, M.D., Ph.D.
for three years to fund his
research into the interactions
of a family of immune-system
molecules called complement.
Hortin's interest is in the basic
operation of the complement
"cascade," a series of consec
utive reactions in which com
plement molecules interact
with one another like domi
noes, one's activity triggering
that of the next.
The cascade is activated by
the binding of antibodies to
invading bacteria or other
foreign particles. As a result,
bacteria are killed and foreign
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particles marked for uptake
into white blood cells.
In some autoimmune di s
eases , such as systemic lupus
erythematosus, the comple
ment system attacks the
body's own cells as well as
bacteria. In thi s illness, char
acterized by fever, fatigue and
skin lesions, complement acti
va tion contributes to kidney
failure and damage to other
vital organs. Hortin seeks to
find ways to shut down the
complement system when it is
damaging normal tissues.
The scholarship program
was established in 1987 as an
extension of the Culpeper
Foundation'S ongoing com
mitment to medical science,
which has totalled approxi
mately $20 million since
1970. The foundation is a
private, non-profit charitable
organization established under
the will of the late Charles E.
Culpeper, one of the early
pioneers in the bottling and
marketing of Coca-Cola. In
recent years, the 50-year-old
foundation has awarded more
than $6 million annually to
activities in health, sc ience,
technology, education, the arts
and administration of justice.
Hortin was one of three re
searchers selected nationwide
from among 50 applicants nom
inated by their respective insti
tutions. The objective of the
program is to support high
achieving young physicians
who are committed to careers
in academic medicine.
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Robert P. Perrillo, M.D., principal investigator of the multicenter hepatitis B study, and research
nurse Carol Bodicky successfully used interferon to treal patients with chrollic hepatitis B.

.Interferon therapy cures
hepatitis B in 11 patients
n intensive course of
interferon therapy
induced remission of
chronic hepatitis B in 38 of
126 treated patients and com
pletely cured 11 of those who
ac hieved remission , according
to the results of a multicenter,
169-patient study coordinated
by Robe rt P. Perrillo, M.D., an
associate professor of medi
cine at Washington University.
The study was published in
August in the New England
Journal of Medicine.
Chronic hepatiti s B is a
serious , debilitating, infectious
Ii ver disorder that predisposes
to c irrhosis and can be fatal.
There has previously been no
cure for the disease. An esti
mated 1 million Americans
are chronically infected with
the hepatiti s B virus, and the
fi sk of primary liver cancer is
at least 100-fold greater in
those individuals. The multi
center study included trials at
12 research centers and is the
first large, controlled study of
its kind.

" We can cure people who
might otherwise have a life
long infection with serious
consequences if we get to them
early enough," says Perrillo,
who is also director of gastro
enterology at the Veterans Ad
ministration Medical Center in
SI. Loui s and served as the
study's principal investigator.
Most cures occurred in
patients who had hepatitis B
for two years or less. Response
was determined by measuring
the amount of replicating virus
in a patient's blood. "Cure"
was defined as the complete
disappearance of virus. Pa
tients in " remission" are those
in whom the virus became
inactive and symptoms dis
appeared. Tests of viral repli
cation were made throughout
the treatment period and at
one, three and six months after
treatment.
"If you ' ve had your hepati
tis less than two years, your
chances of getting rid of the
disease are much better,"
Perrillo says. " We believe this

indicates that early in the infec
tion the virus does not inte
grate its genetic material into
the host cell genetic material.
But if enough time goes by, it
does, at which point total
eradication of the virus may
be impossible. "
The study reports fatigu e
as the most common s ide
effect associated with inter
feron therapy. Other flu-like
symptoms th at occurred in
cluded fever, headache and'
myalgia, but these improved
as therapy continued.
At this time, interferon is
not federally licensed to be
used in the treatment of hep
atitis. Perri I10 says the encour
aging study results may hasten
fed eral approval.
" We have made a signifi
cant step. but long-term fol
low-up will be necessa ry to
determine the frequency of
di sease relapse and long-range
benefits," Perrillo says. " I
think we can feel confident in
telling patients that Ollr rate of
successful treatment with
interferon therapy is abo ut 50
percent overall. " •

~lo]ecula
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cientists at the School
of Medicine have re
ported the first evidence
that as the brain develops, it
employs a SOI1 of molecular
"billboard" to coax axons 
which transmit impulses from
nerve cell to nerve cell - to
grow into a part of the brain
that controls motor behavior.
The research concludes
that a part of the brainstem
called the ba silar pons releases
a molecule that beckons to
nearby axons , inducing them
to bud and extend branches.
This chemical signal influ
ences axons traveling along a
path from the neocortex to the
sp inal cord and in this way
initiates the formation of a
major connection that is essen
tial for controlling movement.
The findings. published in
Science. may have long-range
impl ications for the treatment
of spinal cord injuries that
cause breaks in connection s
from the motor cortex to the
spinal cord.
'This molecule clearly
influences the growth of cor
tico-spinal axons, " explains
Denni s D.M. O'Leary, Ph.D.,
the neuroscientist who head s
the research team. " By study
ing the cellular events in this
process, we can better under
stand what is involved in axon
guidance and branching. This
is crucial to attaining regrowth
and fonning proper connec
tions after spinal injury in
adults."
O'Leary plans to collabo
rate with a biotechnology finn
to isolate the molecule. He
cautions that research on this
novel activity is in the very
early stages, but adds, "If we
can isolate and characterize

this molecule, it might be use
ful to help induce cortico-spi
nal axons to re-establish their
connections after spinal injury."
The mechanism that
O'Leary and his colleagues
describe, called chemotrop
ism, was first suggested by
Nobel Pri ze-winning Spanish
neuroanatomist Ramon y
Cajal near the turn of the cen
tury, but discarded for want of
ev idence. The theory has only
recently gained ex perimental
support.
"Our results provide the
first evidence that in the devel
oping brain, axon targets can
influence the direction of axon
growth and the fonnation of
branches ," says O'Leary.
For thi s project, part of a
series of studies examining
how the neocortex develops
and acquires specific feature s,
the Washington University
scientists studied axons from
layer 5 of the six-layered neo
cortex . Initially, layer 5 axons
grow out of the cortex and
into the spinal cord, bypassing
their targets in the brainstem.
Only later do they fonn
branches at the appropriate
locations along their length.
The branches then grow and
contact their targets, including
the basilar pons, which act s as
a "switchboard" between the
neocortex and the cerebellum.
What cues prompt these
branches to fonn and choose
their targets') To answer that
question , O'Leary and neuro
surgery resident Christopher
D. Heffner, M.D., used a
three-dimensional collagen
matrix, into which they em
bedded pieces of developing
cortex, basilar pons and other
ne ural structures. The matrix

enabled them to look for ac
tivity generated by the basilar
pons. They found that in this
setting the basilar pons re
leases a diffu sible molecule
that induces the fonnation and
directional growth of branches
from layer 5 axons. Based on
this evidence, they suggest
that in the developing brain,
the molecule spreads into the
cortico-spinal axon track ;
there, it functions as a sol1 of
"billboard," inducing axons to
fonn branches and providing
cues to direct their growth into
the basilar pons.
Until now, the prevailing
opinion has been that the pri
mary growth cone - or lead
ing tip - of the axon is re
sponsible for target selection.
But in a previou s article pub
lished in the journal Neuron,
O'Leary and colleague Toshio
Terashima, M.D., reported a
different role for the primary
growth cones of layer 5 axons.
They found that growth
cones guide the primary axons

of layer 5 neurons as they
travel a path past the pon s and
into the spinal cord. However,
the growth cones have no role
in selecting the basilar pons as
a target; rather, thi s is accom
plished by the later branching
of the cortico-spinal primary
axons. That process they now
attribute to the molecule re
leased by the maturing basilar
pons.
"These findings will force
us to re-evaluate the role of
the growth cone in axon tar
geting," says O'leary. "Our
evidence, together with that
recently obtained in other labs,
establishes the long-neglected
chemotropism as a viable
means for setting up neural
connections."
Eventually, the Washington
University scientist s hope to
isolate the diffusible molec ule
they have identified and then
clone its gene. "Applications
to medicine are still light years
away," O ' Leary says, "but the
potential is very exciting."

MERIT ~lalui"i
fot· I(ornfelds

consistent commitment to ex
cellence based on previous
research . Once received , a
five-year grant with MERIT
status may be extended an
additional three to five years,
based on an expedited review
of work accomplished during
the initial period.
" Work in the Kornfeld
laboratory has led to a much
greater understanding of cer
tain rare disorders called lyso
somal storage diseases," said
William H. Danforth, M.D.,
chancellor of Washington
University. "This research
ultimately could lead to the
development of new therapies
to treat these diseases, which
can be crippling and even

tuart A. Kornfeld,
M.D., and Rosalind
Kornfeld , Ph.D., pro
fessors of medicine and bio
chemistry, have rece ived
MERIT status from the Na
tional In stitutes of Health
(NIH) for their latest grant.
The five-year grant from the
National Cancer Institute to
tals $1,715,912. The funding
will enable the Komfelds to
continue research on the bio
chemistry of glycoproteins.
Researchers cannot apply
for MERIT status, but are
chosen in recognition of their
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lethal. We are pleased that
NIH has recognized their
outstanding efforts with this
honor. "
The Kornfelds have helped
to explain how glycoproteins,
molecules with sugar and pro
tein components, are synthe
sized by cells. In particular,
they have elucidated the com
plex machinery used by cells
to form the carbohydrate units
of glycoproteins. These carbo
hydrates are of interest because
they serve as recognition mol
ecules that target proteins to
particular locations in the cell,
such as the lysosome, the
cell's "garbage disposa L"

The Komfelds have shown
that a deficiency of one of the
carbohydrate biosynthes is
enzymes leads to the break
down in the targeting of spe
cific proteins (lysosomal
enzymes) to Iy sosomes. This,
in turn, causes accumulation
of undigested "garbage" in the
cell.
The information on protein
targeting and the role of the
lysosome may be used in
the future to develop new
therapies for detecting and
treating a family of metabolic
disorders that are rare but very
serious.

do,,,-n

the first step in turning fatty
acids into fuel for energy,"
explains Arnold W. Strauss,
M.D. A professor of pediatlics
and biochemistry, Strauss
proposes a scenario for this
type of SIDS: Usually babies
producing a faulty enzyme do
fine. They get their energy
from glucose and glycogen ,
and the deficiency remains
silent. But, if for some reason
- illness, simple colic or pure
accident - an affected infant
doesn't eat for about 15 hours,
trouble occurs.
"That's the threshold,"
Strauss says. He explains that
sugars provide a human's fuel
for only four or five hours,
after which the body shifts
smoothly to fatty acids as its
main source of energy. But if
the changeover is impaired by
a faulty enzyme, energy grad
ually becomes unavailable.
The first organs to fail are the
biggest energy users: the
heart, the brain and the liver.
The lack of fuel alone prob
ably won't kill as rapidly as
SIDS strikes, Strauss says. He

Tra(~king

SIDS
he first biochemical
evidence of one cause
for sudden infant
deatn syndrome (SIDS) is in ,
and it implicates a flaw in how
genetic instructions are decod
ed. Researchers believe the
misinterpretation results in a
faulty enzyme that can't do its
job of converting fatty acids
into energy. Raw materials
subsequently build up to toxic
levels and, too often, an affec
ted infant succumbs to a com
bination of fuel starvation and
self-poisoning.
Experts in the field agree
that SIDS deaths occur from a
variety of causes , most of
which remain mysterious. The
flaw that results in the enzyme
deficiency may be at the root
of only 5 to 10 percent of the
total.
But in those cases, the
problem is with "one of the
three enzymes that catalyze
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thinks that, concurrently, un
used fany acids accumulate
along with camitine, a natural
ly occurring amino acid that
binds to and carries fatty acids
into and out of the mitochon
dria - the cell structures re
sponsible for generating en
ergy. Those accumulations
have a poisonous effect on the
infant's system. Describing
the buildup, Strauss says, "The
elements are highly toxic; if
you inject camitine bound to a
fatty acid into a heart muscle,
it stops immediately."
In less severe cases, infants
sometimes anive at emer
gency rooms with sy mptoms
much like those of Reye 's syn
drome: low blood sugar, liver
failure and vomiting. A quick,
intravenous dose of sugar,
Strauss says, is the medicine
they need. Terrifying for par
ents, such a non-lethal event
might actually be a blessing in
disguise because it identifies a
youngster at ri sk. Further trou
ble can be avoided by guaran
tee ing regular food intake or,
at worst , intravenous sugar
when the child can't eat,
Strau ss says.
'Thi s deficiency occurs in
about one of every 5,000 chil
dren, so it 's not uncommon,"
says Daniel P. Kelly, M.D., an
instructor of medicine at Wash
ington University and one of
Strauss'co llaborators. When a
child is identified as deficient,
family members are screened,
but Kelly and Strauss would
prefer a sc reening test that is
more readily available. That
will require uncoveling the
precise genetic mechanism by
which the faulty enzyme occurs.
However, that mechanism
is complicated and elusive.
The gene that codes for the
enzyme does not appear to be
the culprit. "In many inherited
enzyme deficiencies," says

Strauss, "a mutation on the
gene results in an inefficient
protein. Here, the problem is
something el se. The gene in
deficient patients and in nor
mal controls appears to be
identical. "
So far, the investigators
have traced the trouble to the
process by which precursor
RNA is "spliced" to become
messenger RNA. The proce
dure, simply put, goes like
this: The gene, made up of
informalional islands (exons)
within the DNA molecule is
copied first into precursor
RNA. Most genetic flaws oc
cur in the gene and are passed
along into the first copy.
The precursor RN A is then
"spliced." In thi s step , only
the informationa l bits are pre
served; non-instructive ele
ments (introns) are eliminated.
The result is a compact recipe
for a protein, called messenger
RNA. Finally, the RNA leaves
the cell nucleu s with the in
structions for making the pro
tein. In this case, the protein is
the enzyme known as MeAD.
By working backward
from MeAD to its garbled
messenger RNA and then to
its normal precursor RNA , the
researchers have found the
locu s of the problem. The de
ficiencies that Strauss reports
occur as a result of one or a
combination of 15 different
problems in splicing. The in
structions get confused, and
the product is "a mess ,"
Strauss says.
For the moment, MeAD
deficiency stands as the lone
example of what may be a
new class of genetic disorders
- those attributable not to the
genes them selves but to the
splicing process that is still
poorly understood, though
undoubtedly controlled by
other genes.

Reading old
hones
2-million-year-old ,
fist-sized lump of rock
is helping sc ientists
pry open one of the bottle
nec ks that has restricted a
clear interpretation of human
origins. The lump - reall y a
stone-filled partial sk ull from
a critically important era of
deep prehistory - becomes
only the sixth example of a
pivotal ancestor in human
evolution.
Applying advanced rad iol
ogic techniques, Glenn C.
Conroy, Ph.D., and his
colleagues have made avail
able for study the previo usly
un interpretable skull that
belonged to an animal of the
species Auslralopilhecus
africanus, the earliest known
hominid from southem Africa.
For only the second time, a
specially tuned computed
tomography (CT) scanner has
been used to see through the
rock th at fills a fossil sk ull,
revealing the interior for
study.
Though paleoanthropology
is a field charged with contro
versy, many of its scientists
believe that Auslralopilhecus
africanus may be in a direct
ancestral line to modem
humans. Small and newly
bipedal, A. africanus moved
from the forest to the hot
savannas of Africa not too
long (in evolutionary terms)
before the explosion in brain
size that has s ince character
ized our species. It is therefore
a creature of particular inter
est. But only six skulls identi
fied as belonging to the species
have been unearthed, and
some of them have been less
than ideally informative.

A

Glenn C. Conroy, Ph.D., used the CT scanner to coax information from hominidfossil.
Least helpful among the six
has been the small, partial
skull known only by its muse
um identification number:
MLD 37/38. However, in a
paper published in Science,
Conroy and hi s colleagues,
Michael W. Vannier, M.D.,
and Phillip Y. Tobias, report
on information they have
coaxed that ancient skull to
divulge.
Because MLD 37/38 is
only about hal f of a complete
skull, the anterior portion hav
ing eroded over the eons,
accurate measurement of the
cranial capacity has been
impossible. In evolutionary
studies, cranial capacity is
often accepted as a close
approximation of brain size,
says Conroy, a professor of
anthropology and anatomy.
And for paleoanthropologists ,
precise measurement of a
spec imen's cranial capacity is
important: it places a skull on
the sca le between apes and
humans and relates brain size
to other information about
lifestyle and neurological
organization - valuable data
for theorizing about evolution

ary trends and timetables.
Estimates of the capacity of
MLD 37/38 by ex perts using
external skull measurements
have varied by about 10 per
cent, from 435 to 482 cubic
centimeters. Such estimates
are troublesome, Conroy says,
becau se the fo ssil in question
" has neither a modem human
nor modem pongid (ape)
shaped skull," and those are
the two large models on which
such estimates are based. Be
cause the skull is completely
filled in with solid limestone,
even measuring the thickness
of the skull's bone has bee n
impossible.
Using computer programs
written for the task, Conroy
and Vannier, a professor of
radiology, achieved a precise
value for the skull's capacity,
putting to rest the controversy.
Vannier adjusted the scanner
to "see" through the rock that
fill s the cavity, enabling the
investi gators to make two-mil
limeter-thick image slices of
the intact portion of the skull.
The endocranial volumes were
then computed.
The researchers al so devel

oped a new technique to re
construct the missi ng parts of
the skull, flrst computer-gen
erating a slice that formed a
symmetrical fit with the pre
viou s slice, then another on
top of that one and so on. The
generated slices were opaci
fied on the computer screen
and added to the stack. Half
of the complete image's 46
slices were created in that
way.
By adding the volume of
the preserved portion to the
volume of the reconstructed
portion, they determined a
total capacity for the skull.
The result was a reliable fig
ure of 425 cubic centimeters,
at the low end of all previous
estimates and , Conroy says,
" the lowest endocranial capac
ity for any adult specimen of
A. africanus to date. "
As a result of the MLD
37/38 data, the mean cranial
capac ity for all known A.
africanus e xamples drops to
440.3 centimeters, about one
third of a modem human 's
and roughly half that of our
more recent ancestor, Homo
ereelus.
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Barnes Hospital and the Washington University School of Medicine shortly after the 1915 dedication.
t happened 75 years ago. There
was a hu ge medical celebration
here at Euclid and Kingshighway
in SI. Lo uis. No event since has ap
proached it in scope. The compl e
tion o f the three original buildings
of the School of Medicine called
for a magnificent dedication. The
new Barnes Hospital had been
dedicated a few months before.
The whole nation was to hear about the
new medical facility to be launched in the
West. The three new buildings, of striking
ly similar architecture, now referred to as
South, North , and West buildings, would
house the laboratori es of the new school.
(The West Building had been known as the
Clinic Building during it s first 45 years,
because outpatients were seen there. )
Robert Somers Brookings had rea lized
his dream. This truly remarkable man had
worked steadily for six years to accom
plish the tremendo us facility now to be
dedicated. As president of the Corporation
of Washington University, Brookings had
devoted most of his efforts, from 1909 to
191 S, toward building a first-rate med ical

9

school. The cause gripped his attention as
not even the reorgani zat ion of Washington .
University had done before.
Brookings had come to St. Louis at the
age of 17, and had been gi ven a job by
Samuel Cuppl es, a manufacturer's agent
for all types of woodenware, from clothes
pins to wooden bowls and spoon s. Young
Robert had later become a member of the
firm at age 21. He subsequently amassed a
sizable fortune; but, in middle life, turned
his abundant energy toward the university,
first establishing the Lindell and Skinker
campus , and then building an excellent
medical school. Brookings himself had not
graduated from high school.
Writing about Brookings and the new
medical school, Hagedorn * noted: "It was
so completely alien to his past experience
that he had no ha lf knowledge to confuse
him. He knew nothing of medical educa
tion, and he knew that he knew nothing,
which was the beginning of wisdom. He
visited John s Hopkin s and the newl y com
pleted Harvard Medical School, observing,
conferring, asking unexpected, challenging
questions, listening as he never had lis
te ned in his life. He went abroad and spent
a year studying medica l education in Great
Britain and on the Continent. . .It did not
seem to occur to him that the selection of a
medical faculty might be regarded as out
side his province . He had made the Medical
School so comple tely his life, that he him
self was unconsciou s that there were
bound s to his authority."
Brookings had recruited the young men
in 1910-11 who formed the nucleus of the
original faculty: George Dock, M.D., in
Internal Medicine, Philip Shaffe r, Ph.D. ,
(age 29) in Biochemistry, Euge ne Opie,
M.D. , in Pathology, and Joseph Erlanger,
M.D. , in Physiology. It was Erlanger who
had stipulated that the new faculty should
be allowed to se lect their own dean. This
was the beginning of the Executive Faculty
system of governance for the sc hool. Dock
was selected to be the first dean , serving
for two years. He was followed by Opie,
who was dean at the time of the ceremony.
The dedication of the new building took
place in April 1915. World War [ was rag
ing in Europe, but the United States would
not enter for ano ther two years. Women
were not yet allowed to vote. Radio had
not been invented . There were a few auto
mobiles in the streets, but the horse and
buggy was still dominant. Trolley cars

• HURed()m. Hermall. BI'()()kings: a hiogFOphr.
Macmillan 1936 .
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were the best means of transportation in
the city. They were abundant.
From about 1830 to 1870, St. Louis had
grown very rapidly. For a blief time, be
tween 1870 and 1875, St. Louis laid claim
to being the third largest ci ty in the coun
try. The census at the time, however, was
disputed. The railroad became the primary
means of cross coun try transportation be
tween 1870 and 1915; and in April 1915,

Robert S. Brookings

St. Loui s was a great rail center. U nion
Station w a ~ then nearly 20 years old.
he gala ceremonies began at 10 a.m.
on T hursday, April 29. A procession
formed in fro nt of B ames Hospital.
The admin istrative officers of th e
university led the parade, as they do
nowadays at commencement. The d istin
guis hed delegates from other universities

were next in line. These were follo wed by
the guests and finally by the faculty of the
med ical school. At 10:30 a.m., exercises
took place in the Assembly Hall in the
North Building (today called the Carl V.
Moore A ud itorium).
The presiding office r was Acting Chan
cellor Frede ric Aldin Hall. He introduced
the Right Reverend Daniel Sylvester
Tuttle, Bishop of the Diocese of Missouri,
who offered a praye r. Chancellor I lall then
introduced Robert Somers Brookings, pres
ident of the corporation.
Brookings concluded his brief address
as follows: "We hope that our efforts will
contribute, in so me measure, to raising the
standard of medical education in the West,
and that we will add , through research
activities, our fair quota to the sum of the
world's knowledge of m edicine. " In view
of what has happened since, it was to be an
unde rstatement.

Johns Hopkin s, and Simon Flexner of the
Rockefeller Institute. A total of 33 other
distinguished delegates were also presented.
Subsequently, an " Address for the Fac
ulty by the D ean of the Medical School"
was given by O pie (who was still working
many years later at the Rockefeller Uni
versity at the age of 95). Opie gave an
address of some length. It is remarkable
that he was the only speaker in the three
day period to mention World War 1. He
commented: "Whatever view is taken of
the significance of the struggle which has
possession of Europe few can den y that it
brings into bold relief truths that are often
forgotte n. Science has no nationality, but
national strength today is dependent upon
the recognition of the value of sc ie nce and
its application to the ro utine of living."
Fifty-five years later, in 1970, Opie*,
looking back and writing at the Rocke feller
U niversity in Ne w York, stated : "]n an ad

Willimn H . Welch, M.D. (left) and George E. Vince nt
Following Brookings, T heodore Carl
Link, the architect, presented the buildings.
T he keys were accepted by the chancellor.
Walter Eugene Gan'ey, associate professor
of physiology, then presented the delegates
from other institutions of learning to
Brookings and Hall. Among the presentees
were President Abbott Lawrence Lowell of
Harvard, Professor Rudolph Matas of
T ulane, Professor T heodore Janeway of

dress at the dedication of the new buildings
of the medical school, I described what
seemed to me the spirit of the young men
who had committed themselves to the es

* Opie . EL

, Adoption of Standard,. oflhe Be'>l Medi
cal Schools o.lWestern Europe hy th()se of Ihe United
SImes , Perspeclives in Binlog)' and kledicine. Spring

tablishment of a medical school of the high
est type." Later he rote some words whi h
are priceless in giving LI S a clear fi rsthand
picture of Robert Brookings: "Thc aims of
Mr. B rookings, president of the corpora
tion, were essentially identical with tho e
of the medical group ". He was anxious to
obtain advice when medical problems were
under consideration but was persuasive and
preferred to talk rather than to listen. His
usual procedure was to state the maIler in
his own terms and lhen talk about it . unless
prevented, until he was about to lea e; nev
ertheless, he would listen if urged and
would change an opinion wh n he received
good evidence to contradict it. He had no
compelling urge to vindicate an opinion
that he had once expressed. Without the e n
thu siasm of Mr. Brookings the reorgani z a~
lion of the school would nOI have been un
dertaken and financed."

t the remarkable ceremonies of 1915,
the speaker who followed Opie was
William Henry Welch . M.D., of
Johns Hopkins inivcr. ity. J udging
from hi s status at the time, and p r
haps from the leng th of h i ~ address, he was
evidently the main speaker. His presence
elevated the dedication of the new build
ings to an event of national significance.
In the hi story of American medicine, no
other person before or since has ever reach
ed the pinnacle of public recognilion as that
achieved by Welch. lf ever there wa ' a man
born at the right time, educated in all the
right places. and e levated to prominence in
a time of great need, it was William Henry
Welch. Born in 1850, he graduated from
medical school in this country and had
studied physiology with Carl Ludwig in
Leipzig in 1876. He learned pathology wi th
J uliLls Cohnheim in Breslau in 1877, and
took Robert Koch 's course in bacteriology
in 1885. Welch later discove red the bacillus
which bears his name. He became profes 
sor of pathology and the fi rst dean at the
Jolms Hopkins University School of
Medicine.
Simon F eXller* expresses the phenom
enon of Welch in enviable prose: " t 35
Welch had found his place in the worJd .. .
for many years a genie con ftned in a bOllle,
he rose up, once the cork was pulled , into
hi s true dimensions, and for almost SO }vars

" Flexner. S., alld FleXileI'. IT.. WillialJl Hellry )l ei. h
and the Heroic Age of Amerh an Medi( ille. Om"a
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he was to tower over American medicine,
detelmining, creating , helping change a
backward profession into a leading profes
sion of his time." He led American medi
cine away from the proprietary school s of
the nineteenth century, and into the scien
tific era of the twentieth.
Welch was a lifelong bachelor, of ample
gi11h, with a fami li ar mustache and goatee
affectionately referred to as "Popsy". He
was a father figure to two generation s of
young American scientists. Furthermore, he
was always available to help launch new
institutions, always ready to boost new
programs in medical education and science.
In 1930, on Welch's 80th birthday, Presi
dent Hoover delivered a speciaJ broadcast
on major radio networks: "Dr. Welch is our
greatest statesman in the field of public
health ," he began. Thi s tribute was broad
cast across the ocean on short wave and
retransmitted from London throughout the
British Isles and on the Continent. Simul
taneous ceremonies took place in London,
Paris, Geneva and Tokyo. In this truly re
markable fashion, "Popsy's" 80th birthday
was celebrated.
In St. Louis, in 1915, Welch began his
address: "One of the most significant
events in the recent hi story of medical edu
cation in America, significant especial ly for
the South and West or thi s coun try, has been
the reorganization of the Washington Un i
versi ty medical school in accordance with
the most advanced standards of modern
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medical teaching and research. " He con 
tinued a bit later: "I desire likewise to com
mend the high wisdom of the trustees of
Bames Hospital and of the St. Loui s Chil 
dren's Hospital, who, by entering into affil
iation with the university and by placing
the professional service in the hands of the
medical faculty, have made these in stitu
tion s free ly available for teaching and the
advancement of medical knowledge, there
by rendering them of far greater service
than otherwise both to patients and to the
community." Welch conc luded his address
by saying that the City of St. Louis must
fee l a justifiable pride in the new medical
school.
fter lunch on April 29, the weather
having warmed up a bit, the ad
dresses were continued on the lawn
of the medical school between the
NOl1h and South buildings (where
the new library now stands). The speaker
was President Abbott Lawrence Lowell of
Harvard. Chance llor Hall introduced him
wi th a deft historical touc h: " Upon the
fOimal inauguration of Washington Uni
versity, April 22, 1857, Harvard College
was called upon to fumish the orator of the

r r"

m. ().
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day in the person of Edward Everett. This
aftemoon, 58 years later ... Harvard again
con tributes the first speaker, President
Abbott Lawrence Lowell. " President
Lowell presented a di ssertation on medi
cine as a public serv ice.
One of the speakers later that aftemoon,
President George Edgar Vincent of the Uni
versity of Minnesota, indicating his inten
tion to speak briefly, acknowledged the
thunderous noi se of the street-cars on
Euclid Avenue. He said : "The patient, self
controlled congregations in coloni al New
England were wont to watch with hope the
spending hour-glass by the preacher's side.
We have today, in these pass ing troll ey
cars, a modem equivalent of the old device.
I understand that the periodicity of these
rattling shuttles is about three minutes. Let
me reassure you at the outset: [ shall detain
you only two or three cars." At 4 p.m. there
was a garden party on the grounds of the
medical school, and the guests were guided
through the laboratories, and the Bames
Hospital, anu SI. Louis Children 's Hospital.
On the moming of April 30, 1915, ad
dresses of welcome were given in the
Assembly Hall to the alumni of the medical
school. Professor Robert James Terry , the
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only full-time member of the old faculty to
be retai ned following Abraham F1exner's
scathing review of the Medical Department
of Washington University, spoke of devel
opments which led to the new school. That
afternoon, again out of doors on the lawn ,
Professor George Dock spoke of the rela
tionship of the university hospital to the
community. Following Dock, there was a
speaker of tremendous celebrity, a hero of
the day, in 1915 , General William
Crawford Gorgas, Surgeon-General of the
United States Army. Gorgas and his men
had just accomplished one of the greatest
feats in the history of preventive medicine.
He described their efforts in successfully
eradicating the mosquito from Havana and
later from the Isthmus of Panama. Thus,
the elimination of malaria and yellow fever
had made possible the construction of the
Panama Canal, which had been completed
just the year before.
At 8 p.m. , an academic procession
formed in Ridgely Library on the univer
sity campus and proceeded to Graham
Chapel, where honorary degrees were con
felTed by Chancellor Hall upon, among
others: Janeway , Matas, Gorgas, Flexner,
Welch , Vincent and Lowell.

m.o.

n April 28 there had been exercises
held in commemoration of William
Beaumont, M.D. , on the occasion of
the presentation of hi s manuscripts
and leners, given by his grand
daughter, Miss L. Beaumont Irwin, to the
Washington University medical school.
Beaumont, of course, was the army sur
geon who had observed the motions of the
stomach of a Canadian trapper through an
opening made by a shotgun wound. The
patient, young Alexis St. Martin, had been
dangerously wounded by the accidental
discharge of the weapon. St. Martin even
tually made a complete recovery except for
the permanent opening through the abdom
inal wall into the stomach. From 1825
through 1833, Beaumont had carried out
238 experiments on his subject, which
formed the basis of his book entitled:
"Experiments and Observations on the
Gastric Juice and the Physiology of Diges
tion". During the exercises here in 1915, it
was Professor Joseph Erlanger who ex
plained the enormous impact on the world
of physiology made by Beaumont in 1833.
Erlanger pointed out that 70 years after
Beaumont's book Osler had characterized
him as "the pioneer physiologist of this

country, the first to make an important and
enduring contribution to this science. "
Twenty-nine years later, in 1944, Joseph
Erlanger and Herbert Gasser, M.D.,
received the Nobel Prize for their work in
the South Building on the conduction of
impul ses by nerves.
There were, of course, distinguished in
vitees to the ceremonies who were unable
to anend. William Osler, Regiu s Professor
of Medicine at Oxford, wrote to send his
warmest congratulations but stated he
could not attend because of the war.
Three-quarters of a century later. those
of us working at the Washington University
School of Medicine in 1990 can look back
with great satisfaction upon the accom
plishments of the physicians and sc ientist s
who have worked here. Gerty and Carl
Cori were awarded the Nobel Prize in 1947
for their investigation, in the South Build
ing, of the cycle which is required to
change glucose into glycogen and back.
Those men, in 1915, had looked forward
with hope and great expectations. Similarly,
we can look back with tremendous pride.
Biomedical science continues today at the
laboratory bench in the North, South and
West buildings. Given the tremendous
progress the school has made in this cen
tury , we can anticipate great accomplish
ments from it in the century just around the
comer.
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Cardiologists Steven R. Bergmann, M.D., Ph.D., (left) and Edward M. Gettman, M.D.,
use PET to view the heart's metabolism. PET promises to shed new light on heart
problems that have puzzled cardiologists for a long time.
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f it leaks, replace it. If it's clogged,
force it open. If it doesn't work at
ali, get a new one.
Sounds like good plumbing
advice, but also it's been the
thinking behind many phenomenal
advances in modem cardiology.
Valve replacement therapy, bypass surgery,
balloon angioplasty, transplantation 
these therapies all treat the heart on a
structural level, as a pump, according to
Burton E. Sobel, M.D., Tobias and Hortense
Lewin Professor of Cardiovascular Dis
eases.
But because the heart is not made of
stone or plastic or steel, but of living cells
- each with a tiny structure of its own 
the heaI1 cannot always be fixed by repair
ing its anatomical plumbing. Sudden death
and certain chronic disorders of the heart
m uscle, for example, do not appear to be
associated with any obvious anatomical
defects and may have more to do with the
heart cells themselves.
They could be starved for blood or run
ning low on fuels ordinarily carried in the
blood. Or the cells may be unable to meta
bolize these fuels .
Until recently, cardiologists could not
study such metabolic problems without
snipping, or biopsying, pieces from the
heart. But now researchers at the School of
Medicine are using a new method that
places the whole heart in a test tube, so-to
speak, without disturbing a single cell.
The new method, called positron emis
sion tomography, or PET, produces images
of the heart by detecting radioactively la
beled molecules as they are used by the
heart. Patients and research subjects who
undergo PET are injected with these tracer
molecules and placed in a doughnut
shaped macmne that detects radioactive
decay in three dimensions. Then, by com
pletely automated number crunching , com
puters transform this raw data into a series
of 3-D images that resemble topographical
maps. But instead of mapping geograph
ical highs and lows, PET maps the highs
and lows of blood flow and metabolism.
By reading these maps, cardiologists
can pinpoint areas within the heart that
may be injured, dead or functioning abnor
mally. T hey can also predict whether these
areas can recover and how to enhance thi s
recovery. "The promise is that disorders of
the heart muscle that have remained cryp
tic and difficult to fathom can now be,
theoretically at least, plumbed and better
understood and, ultimately, better treated,"
Sobel explains.
Because the tracer molecules used in
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A positron emission tomography
(PET) scan obtainedl from a patient
with cardiomyopathy. In this and all
subsequent figures , the images are
displayed as if the body was cut
transversely. Uptake of carbon-11
palmitate in patients with cardiomyo
pathy is non-uniform, indicative of
regional heterogeneity in fatty acid
metabolism. The liver, which al'so
uses fatty acids, can be seen to the
left in th is image.

~

Transverse myocardial images ob
tained from a normal human volun
teer (left) and a patient with an acute
myocardial infarction (right.) The
right image shows that the effected
anterior myocardium, deprived of its
blood supply, has diminished oxygen
consumption. Sequential scans may
be used to eval uate the effects of
interventional therapies on myocar
dial metabolism .

Transverse myocardial tomograms
obtained from a patient with coro
nary artery disease before (left) and
after (right) coronary angioplasty.
These images were obtained after the
administration of oxygen-15 labeled
water which permits estimation of
myocardial perfusion (blood flow) .
Perfusion is restored after angio
plasty (right).

PET are chemically indistinguishable (ex
cept for their radiolabels) from substances
that the heart metabolizes every day, PET
does not disturb the heart's normal physiol
ogy like dyes and other foreign tracers
might. Lnstead, it provides cardiologists with
a front-row seat to the heart's biochemistry.
What the cardiologist sees depends on
the type of tracer that's used. Radioactively

labeled glucose, for instance, will show
how the heart breaks down sugar. A radio
labeled fatty acid, on the other hand, will
reveal a picture of fatty acid metabolism.
\Vashington University cardiologists
first began to use PET about 13 years ago
to measure the amount of dead tissue left
behind after heart attacks. They wanted to
know whether the size of infarcts - areas

of dead tissue that arise when an area of the
heart is cut off from its blood supply - had
anything to do with their patieni" chances
for recovery.
PET gave them the answer. Using car
bon 1 I -labeled palmitate - a fatty acid
that is rapidly taken up by heart tissues and
converted into carbon dioxide and watcr
they were able to measure the extent of
these infarcts. Because damaged, or infarct
ed, tiss ues did not absorb or metabolize the
radiola beled palmi tate like their healthy
counterparts, infarcts appeared dark in con
trast with the hot, bright, tracer-laden
regions of healthy tissues. So by imaging
the uptake and depletion of this physiolog
ical tracer and comparing the images with
patient outcomes, School of Medicine car
diologi sts were able to concl ude that
patients with larger infarcts do not recover
as well as patients with smaller infarcts.
PET also helped gain the widespread
acceptance of thrombolytic therapy in
which the victims of heart attacks are treat
ed with clot-bursti ng drugs that open up the
coronary nrteries and return blood flow to
the heart. Armed with PET images taken
before and after thrombolytic therapy,
Washington University cardiologists demon
strated conclusively that forcing open the
coronary arteries with clot-dissolving drugs
spares heart muscle. These studies won
over many skeptics, helping to entrench
throm tlolytic therapy as a front-line therapy
for heart attacks.
More recent PET studies by Steven R.
Bergmann, M.D., Ph.D. and Edward M .
Geltman, M.D. have further elucidated the
recovery process that occurs after throm
bolytic therapy. Using radio labeled water
as a tracer for blood flow and carbon 11
labeled acetate as a tracer for oxygen meta
bolism, these associate professors of medi
cine have learned that the return of normal
blood flow is the first manifestation of the
hea rt 's road to recovery. But for the heart to
completely recover normal functions, it
must fi rst resume normal oxygen meta
boli sm - a process that takes about a week.
Bergmann and Geltman are now using
PET to see if they can somehow speed up
the recovery of normal oxygen metabolism
by adm ini stering certain drugs in conjunc
tion with the clot-dissolving drugs t- PA and
streptokinase. PET may not only prove in
valuable in evaluating the effectiveness of
these and other new drugs, but also may
prove useful in eval uating the need for and
the effectiveness of cl inical procedures
such as bypass surgery and angioplasty (a
procedure in which blood vessels are open
ed up with a balloon-like device).

Geltman and Robert J. GrapIer, M.D.,
an instructor in radiology, are now investi
gating whether or not they can use PET to
predict the likelihood of heart tissue recov
ery after angioplasty or bypass surgery in
angina patients. It is difficult, if not impos
sible, to make such predictions using any
other currently available diagnostic tech
niques, according to Geltman.
He and Grapier hypothesize that , al
though stunned heart muscle can survive
short periods of time without oxygen
(through anaerobic metabolism), it cannot
live indefinitely without this vital nutrient.

"'The promise is that
disorders of the heart muscle
that have remained cryptic
and difficult to fathom can
now be, theoretically at least,
plumbed and better under
stood and, ultimately, better
treated, " Sobel explains.

Geltman and Gropler can use PET to mea
sure the ratio of oxygen metabolism to non
oxygen metabolism, which they believe
may be the best predictor of heart muscle
recovery.
Beyond PET's evaluative and predictive
uses, PET promises to shed new light on
heart problems that have puzzled cardiolo
gists for a long time. PET offers new hope
for heart transplant patients who, for reasons
unknown, tend to develop an accelerated
version of coronary artery disease. "Some
people get hearts from very young adults.
Yet fi ve years later these hearts look like
the hearts of 80-year-olds, and may even
require retransplantation," says Bergmann.
As a result, all heart transplant recipients
must frequently undergo coronary catheter
ization to monitor them for coronary artery
disease. This procedure is invasive and not
without risk.
Bergmann and Geltman are now work
ing with Sobel, Edward T.A. Fry, M.D.,
and cardiology fellow Martha J. Sennoff,
M.D., to see if they can use PET to detect
blood flow problems in the heart as soon as
they start. And they are also using PET to
explore why transplant patients experience
this problem in the first place. Says Sobel,
"Cardiac PET may be important in defining

the mechanisms of the ultimate failure of
transplants in some patients, while protect
ing individual patients against such failures
by identifying them early."
PET also promises to be important in the
diagnosis and treatment of people with syn
drome X - a condition in which patients ex
perience the chest pains and shortness of
breath that typifies coronary artery disease.
yet their arteries show no signs of narrow
ing when they undergo coronary catheteri
zation.
By monitoring these patients' blood flow
under a drug-induced state that mimics exer
cise, Bergmann has discovered that roughly
half of these people are unable to increase
the blood flow to their heart muscle. "There
must be some intrinsic defect that interferes
with their ability to raise blood flow for nor
mal everyday activities like walking up the
stairs," Bergmann says. "The next step is Lo
use PET to evaluate a number of drugs that
we feel may be beneficial to these people,"
Sobel is especially excited about PET's
ability to distinguish between heart muscle
disorders that are caused by coronary artery
disease and those associated with other prob
lems such as muscular dystrophy, chronic
alcohol abuse, or infectious processes. Under
PET, heart muscle disorders that are caused
by coronary artery disease show a patchy
distribution of carbon II-labeled palmitate,
while heart muscle disorders caused by
other problems show a homogeneous up
take and removal of this tracer.
It is significant that these heart muscle
disorders are symptomatically similar yet
yield different PET images. Being able to
tell the difference between these problems
is important clinically because heart muscle
disorders caused by coronary artery disease
are treated differently from other heart
muscle disorders. Bypass surgery, for exam
ple, might help in the case of a coronary
artery-disease-induced disorder, but would
not be much help for a disorder attributable
to alcohol.
"Just the fact that we can look at two
hearts with the same dimensions and pump
ing impairment and see that they are very
different metabolically is a very big step
forward," Sobel says. "PET's endpoints are
not anatomic. The important questions are
not only - is the valve working better, is
the hole in the septum fixed, or is the coro
nary artery opened up - but rather - does
the heart muscle behave normally from a
metabolic point of view, and is the micro
vasculature behaving more normally in
terms of delivering blood flow on a cell-to
cell basis?" he says. "We really have no other
way to answer these questions."
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BY ROBERT LOWE S

M

ost babies can roll over by the time they're four or five

months old. Katrina Becker couldn't until her seventh month.
That was one of the first clues.
The blond-haired, blue-eyed daughter of Rose and Erwin Becker, a
St. Louis area couple, reached other developmental milestones some
what behind schedule -

crawling, sitting, standing. And she didn't

smile much. The Beckers sent their listless, frail-looking child to a
physical therapist for her poor muscle tone, but their anxieties
persisted. Why wasn't Katrina progressing like other children?

Ruse Becker, Katrina Becker and
S. Bruce Dowtof!, M.D.

l8

•

...
The Possum (Pictures of Standard Syndromes and Undiagnosed Ma({ormatiolls) computer catalogues more thall 1,000 diseases,
listillg likely diagnose!; and iIlustratillg them witll allY of 25,000 photographs alld video clips.
Then in December 1989, her pediatri
cian told the Beckers that Katrina's urine
contained massive amounts of methyl
malonic acid. Katrina was referred to the
Medical Genetics Division of Child ren 's
Hospital, part of the Washington Univer
sity Medical Center. The little gi rl became
one of the 1,000 patients seen each year by
these medical detectives who decipher dis
eases in the alphabet soup of human chro
mosomes.
The chief detective, S. Bruce Dowton,
M.D., director of the division, called the
Beckers in early February and said he had
pinpointed the cause of Katrina 's s low
development. Come to my office without
Katrina, he said. Tomorrow. The urgent
instruction further deepened the Becker's
fears, which now involved yet another life
- Rose was two months pregnant.
The next day, the Australian-born
Dowton told the Beckers that Katrina had
methyl malonic aciduria, a genetic disorder
that impaired her ability to break down
four amino acids. As a result, meth yl
malonic acid had built up in her body,
affecting brain centers in charge of muscle
tone and coordination. Rose and Erwin
each carried a recessive gene for the dis
ease, but they themselves did not suffer
from it. Katrina had inherited one gene
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from each parent, giving her the prerequi 
site pair to upset her metabolism.
The odds of that happening were about
one in 50,000.

L.

odds of Katrina li ving an acti ve,
norrnallife are anything but a long shot,
however, thanks to dietary therapy and
vitamin B-12 injections. For Dowton,
Katrina ' 5 story is one of many bright spots
in the growing, but still baffling, fie ld of
medical genetics. More severe and some
times fatal genetic diseases leave parents
questio ning whether life - or God - is
fair. Cystic fibrosis clogs the lungs with
thick mucus. Duchenne's mu scular dystro
phy ravages skeletal muscle. Down's syn
drome produces severe mental retardation.
Researchers hav e identified approxi
mately 2,000 genetic disorders, some so
rare that less than a dozen cases may ap
pear in medical literature. Dowton's chal
lenge is identifying these maladies in pa
tients, some of them adu lts, who come to
the Medical Genetics Division from all
over the M idwest. To gather clues, he and
his staff ponder the details of a patient's
appearance, analyze the DNA with geneti
cally-engineered probes, peer through

mic roscopes , search a com pute r data base
and correspond w ith physicians around the
world who have treated sim ilar cases.
"Beca use indiv id ual diseases are often
qui te rare, we're fo rced 10 cas t a ve ry wide
ne t,"' says Dowton , 3n assi stant professor
of genetics as well as pediatri c ~ at the
School of Medic ine.
111e work of the Medical Genetics D ivi
sion doesn 't stop at diagnosis. Parents are
co unseled about the long-ternl care and
treat ment of their children as well as pros
pects of future chil dren inheritLng a disorder.
Dowton 's staff stee rs Fam ilie" th rough the
health-care maze to other phy s i c ian ~ and
institutions that specialize in a given illness.
Parents of affected children also need psy
chological healing and hope. and Dowton.
a father of two, is ready to offer that as well.
"His personal commitme nt and caring
have reall y made things a lot easier for us,"'
says Erwin Becker, a meta.llurgist w ith
Cerro Copper Products Co. in Sl. Lou is.
O n any given day, Dowton may see pa
tien ts with defective hearts, osteoporos is.
renal dysfunction , astigmatism or deaf
ness. T he special ty of genetic medicine
turns its practitioners into gene ralists,
Dowlon says in his down- under accen t. "r
happen to like it. "

•

•
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Medical Genetics Division en
compasses all congenital disorders, some
of which can'r be blamed on a recogniz
ably fa ulty DNA blueprint. In some cases,
the cause of cleft palate and club foot, for
example, is multifactorial in nature.
"Genetic and congenital diseases are
now the most common causes of death in
the first year of life ," says Dowton. "They
have actually overtaken premature birth as
a cause of death. That simply reflects that
neonatal techniques are so much improved
now to keep very sma ll babies growing.
"About 3 percent of all children born
will have a genetic or congenital disease
that will require medical intervention.
That's much higher than most people
realize."
Ge netic diseases originate in the 23
pairs of human chromosomes. Each chro
mosome is a framework for thousands of
DN A-bearing genes that produce proteins
and chemicals goveming everything from
intelli gence to eye color. Nature can scram
ble the genetic code in any number of
ways. Add an extra chromosome to a pair
and the result is a trisomic syndrome such
as Down's syndrome. When one of the two
chromosomes in a set is missing, you have
a monosomic syndrome such as Tumer's
syndrome, which causes short stature in
females. Other diseases stem from a chro
mosome lacking an individual gene or a
set of genes. Or a gene may be in the
wrong spot on the chromosome, or in the
right spot, but in a mutated form.
Di agnosis of a possible genetic disorder
begins with a complete medical history
and an examination that focuses on many
physical features including details such as
the distance between the nose and the up
per lip, the shape of the ear and the texture
of the hair. No sing le feature announces
the existence of a genetic problem; rather,
Dowton is looking for a constellation of
unusual features. By itself, fine, sparse
hair is not cause for alarm, but together
with cone-shaped teeth, prominent lips
and a low nasal bridge, it may signal a
form of ectodermal dysplasia, whose vic
tims cannot sweat.
Biochemical diagnostics also yields
valuable clues. The Medical Genetics
Division subjects urine, blood and spinal
fluid samples , for instance, to gas chroma
tography and mass spectrometry. These
procedures can ide ntify compounds
such as methylmalonic ac id in the case of
Katrina Becker - that have built up in
body fluids due to metabolism gone
haywire.

Cytogenetic diagnostics lets Dowton 's
staff study culpable chromosomes directly.
A blood or skin sample from the patient is
grown in a tissue culture. The chromo
somes are then isolated and examined
under a high-powered microscope. This
technique allows a geneticist to spot an
obvious anomaly such as an extra chromo
some. Or the geneticist might see a crimp
in the sex-determining X chromosome,
which gives the name to the fragile X syn
drome, a common cause of mental retar
dation in boys.
But to fine-tune genetic diagnoses, you
need to study not only individual chromo
somes, but individual genes and their loca
tions on chromosomes. Recently devel-

Counseling plays a major role ill the
hlllldreds of cot/sullat;om; performed
each year by Do wton.
oped DNA probes make this possible. The
probe itself is a section of a normal chro
mosome cloned in large quantities from
bacteria.
"You're looking for the probe to bind to
its complementary sequence in the per
son's genes," says Dowton. If a patient
lacks a single gene or group of genes, "the
binding will not occur." D A probes can
even map segments of an individual gene
- valuable information for Dowton since
the same gene can cause more than one ill
ness, depending upon the mutation. Thi s
power of differentiation allows geneticists
to distinguish Duchenne 's muscular dys
trophy from a milder version - bom of the
same gene - called Becker's muscular
dystrophy.
DNA probes, which have recently
helped researchers track down individual

genes responsible for cystic fibrosis, colon
cancer, polycystic kidney disease and
neurofibromatosis, for example, will prove
instrumenta l in the Human Genome Pro
ject. This $3 billion effort by the federal
National Institutes of Health and the De
partment of Energy aims to pinpoint the
chromosomal locus of each of our 100,000
or so genes. "We will attain benefits from
that when disease-specific gene s are locat
ed and characterized," says Dow ton . "We
will be able to utilize that information to
help famil ies with diagnoses."

D
owton has yet another high-tech
weapon in his diagnostic arsenal - a
computer data base called Possum, or
Pictures of Standard Syndromes and Un
diagnosed Malformations. It catalogues
more than 1,000 diseases discussed in
1,667 published cases and 1,528 clinical
cases. Tell Possum facts about an uncon
firmed case and the program will list likely
diagnoses and illustrate them with any of
25,000 photographs and video clips on a
television screen.
Nancy Mendelsohn, M.D., one of three
genetics fellows in the division, recently
demonstrated how smart Possum is. She
called up an exhaustive checklist of phys
ical traits. For the category of face shape,
Mendelsohn checked off "flat." For the
region around the eyes: "up-slanting." For
the location and orientation of the ears:
"low set." After entering a few more traits,
she entered a command for possible diag
noses. Heading the Iist was trisomy 21, or
Down 's syndrome.
Sometimes the Medical Genetics Divi
sion refers cases to similar groups across
the country that test for particular syn
dromes. Dowton recently coordinated
blood testing for one c hild with investiga
tors at Queens College in K ingston,
Ontario, who work with t he gene for
Pelizaeus Merbacher, a syndrome that un
hinges muscular coordination. Dowton 's
division itself attracts cases as a specialty
center. Neurofibromatosis, which spawns
benign tumors, is the domain of Chin-To
Fong, M.D. Berengere De Martinville,
M.D., studies muscular dystrophy while
Michael S.Watson, Ph.D" has made fragile
X syndrome his niche .
Some diseases are triggered only when
a child inherits a pair of flawed chromo
somes, one from each parent. Fragile X
syndrome, however, can strike when just
one crimped X chromosome is present
(every male has at least one feminine X
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chromosome in addition to a masculine Y
chromosome; females have two Xs).
"There can be males carrying the (dam
aged chromosome) who are unaffected,
which is unusual for a genetic disorder of
this kind," says Watson. "That's one of the
mysteries. "

L
o months after their initial visit,
the Beckers once again were seated in a
waiting room at the Me dical G enetics
Division. Katrina, looking chipper, was
pulling herself along from Mom's knees to
Dad's knees and back again.
" Her energy level is much higher,"
Erwin told Dowton and Mendelsohn. " He r
ability to walk around has really improved."
Rose, now three months pregnant, also
was pleased with Katrina's progress, bu t
she voiced worry that her next child would
suffer from methy lmalonic aciduria.
"With the new onc," Dowton said,
smiling, "there's a one-in-four chance. But
turn it around. You have a three-out-of
four chance the child will be normal."
"I know you can't give me a guaran
tee:' said Rose, her hands clutched
together, "but I'm so anxious to find out."
Parents are understandably anxious
when a bad gene aftlicts one child and
casts a shadow on the rest of their repro
ductive future. Dowton has seen the whole
gamut of responses - sadness, guilt,
den ial, anger.
"They often displace that anger on the
medical care system, and we attempt to
absorb and understand how individuals in
this situation feel and react," Dowton says.
"They're unable to deal with the fact they
don't have a peIfect child. Every parent
wants to have a perfect child."
While a few consider putting a serious
ly stricken child up for adoption, most
families rally around their offspring. "I
never cease to be amazed how well parents
deal with this," says Dowton.
Rose and Erwin Beckcr have already
made up their minds about the child whom
Rose is carrying. Both Roman C atholics,
they intend to forgo prenatal diagnosis and
bring forth the new life no matter what.
But genetic medicine already has served
them well. Man's ability to crack the gen
etic code has restored hope for their
daughter Katrina.
"We're grateful that the knowledge is
there so her condition can be treated," says
Erwin Becker. "We don't know what the
future's going to hold, but right now,
things are going very well."
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Parents counseled at the Medical Gene
tics Division ask very common-sense
questions, says Dowton. Will they walk?
Will they talk? Will they go to college?
Will they require surgery at some point?
For a few children like Katrina Becker, the
prospects of a near-normal life are very
promising. A low-protein diet including
special synthetic proteins reduces her
intake of the four amino acids that she
metabolizes poorly. Injections of vitamin
B-12 improve her ability to break down
whatever she does ingest. Dietary therapy
also works wonders for a more widespread
enzyme abnormality called PKU, or
pheny lketonuria, that left untreated can
lead to mental retardation.
With most genetic disorders, however,
the only comforts offered by a diagnosis

"About 3 percent of all
children born will have a
genetic or congenital
disease that will require
medical intervention, That's
much higher than most
people realize. "
are damage control and real istic expecta
tions. Children with fragile X syndrome
are likely to struggle with language skills,
says Watson. If you concentrate on those
skills at an early age, "you can make them
more educable. " Pa rents of a child with
Bloom syndrome, common among Ash
kenazic Jews, know that he has a one-in
four chance of developing malignancies.

"W;:ther they shorten life or shrink its
horizon, genetic diseases break hearts. The
worst advice you can give to families in
such straits, says Dowton, is "get on with
your life ... have another child ... time will
make it all better."
"People have to be given time to deal
with the situation, to grieve appropriately,"
he says. "The loss is al ways there. It won't
go away, but as time goes by, it will
assume the correct place in the family's
life. If they don't accept it, it is often
because they haven't allowed themselves a
chance to grieve."
Sometimes parents ask Dowton if he
can cure a disease by replacing a bad gene

with a good one. Twenty years ago. that
question wasn ' r taken seriously. Today,
with recombinant D NA techniques, cor
recting a person's genetic code cou Id be
around the corner. Last March, an N TH
committee approved a proposal to treat
children with a hereditary immune defi
ciency by inserting nonnal genes into their
blood cells. These children lack a gene
responsible for T-cell production of an
enzyme caJled adenosine e!eaminase, or
AD A. The absence of A DA causes a pro
liferation of toxins that destroy the immune
system.
This condition is popularly known a~
the "bubble boy" syndrome, referring to an
A D A-deficient boy in Texas who li ved in
side a sterile plastic tent to avoid infection.
Researchers want to insert an ADA-pro
ducing gene, derived from a harml e ss
mouse leukemia virus, into a patient \" T
cells. The experimental therapy must c lea r
several more N IH committees as well as
the FDA before clinical trials beg in.
Do wton applauds this governrne nt
financed venture into gene therapy, but he
also urges the government to incre::1sc
funding for current testing and treatment
programs. Frequently, they're not cove red
by health insur::1nce pol icies. W hen cover
age is available, re imbursements tend to be
inadequate, says Dowton, because they're
skewed toward medicine by procedll re , not
long hours of counseling parents, studying
photographs, reading medical literature,
corresponding with physicians and head
scra tching.
" A lot of what we do as g eneticists is
intellectually based time ," says Dowton.
The Me dical Genetics Division at Ch il
dren '.; Hospital already benefits from some
government largesse - specifically, grants
from the states of M is souri an e! Il linois and
the City of St Louis. D o wton is actively
lobbying for more public underwriting.
Government must also step in to help
resolve several ethical issues confronting
genetic medicine, according to Dowton.
Some observers fear that adv::1nced diag
nostics will spawn a "biological under
class" of individuab whose genes reveal
problematic medical futures from day one .
Insurance companies may deny them
coverage for "pre-existing conditions" or
force them to pay excessive premiums.
Discrimination could extend to the job
market. Employers might be leery of hir
ing or promoting someone predisposed to
a hean attack at age 45.
"[ think these are serious questions soci
ety will be forced to face," says Dowton.
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Student Stage
Match Da~' I!190
total of I 13 students
were graduated from
the School of Mt:di 
cine earlier this summer.
Through the alional Resi
dency Matching Program, 83
percent of these graduates
matched with one of their top
three choices for post-gradu
ate clinical training. Sixty
three percent matched with
their number one choice, an
incr'ease over last year.
Internal medicine residen
cies were most popular among
the graduates. General surgery
and pediatrics were also lead
ing selections. Seventy-two of
the I 13 partici pants selected
one of these three fields.

Forty-five of the new physi
cians are staying in Missouri
for their post-graduate training,
most of them at Washington
University Medical Center
hospitals, Other states frequent
ly selected are California:
12; Illinois: 6; Pennsylvania:
6; and Massachusetts: 5.

California
Los Angeles
Cedars Sinai Medical Center
Michael G. Ridgeway.
General Surgery
Scott E. Silverman. Internal
Medicine Preliminary,
University of Southern
California. Opthalmology
Steven R. Stolz . General
Surgery

Harbor-UCLA Medical
Center
Iris Wagman Borowsky,
Pediatrics
VAMC West Los Angeles
Ian Yip, Internal Medicine
Oakland
Kaiser Pennanente Medical
C enter
Andreas E. Helle r, General
Surgery
Pasadena
Huntington Memorial
Hospital
Jeanne C. Tsai. Internal
Medicine
San Diego
Mercy Hospital
Maki C. Goskowic z,
Transitional
University of California San
Diego Medical Center

Thomas R, McMinn,
Internal Medicine
Stanford
Stanford Affiliated Hospitals
George G. Gibbs, Internal
Medicine
Robert M. Jasmer, Internal
Medicine
Carl Y. Owada, Pediatrics

Colorado
Dem'N
University of Colorado
School of Medicine
Gladys A. Richardson.
Family Practice
Thomas R. Vendegna,
Internal Medicine

Connecticut
New 1-/0\'1'11
Yale-New Haven Hospital
David W. Drucker, Internal
Medicine

I

011 Match Day: Peter Apicella

(l~ft) ,

Mitchell Fremlillg alld Gyan Brard.
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Massachusettes
Boston
Brigham & Womens Hospita l
Roger C. Inhorn, Internal
Medicine
Bradley J. Quade, Pathology
Edwin K. Silvennan,
Internal Medicine
Chi ldren 's Hospital
Victoria R. Masako wski,
Pediatrics
Camhridge
Mount Auburn Hospital
Justin F. Thulin , Internal
Medicine Preliminary

SIe ve" Katie and Marianne Sweetser.

Leigh V. Evans, General
Surgery
Yale/Waterbury Hospi tal
Neil 1. Silvennan, Internal
Medicine Preliminary
Illinois
Belleville
Scott Air Force Base
Paul L. Dassow, Family
Practice
Chicago
Children's Memorial Hospital
Kirsten M. Baker, PediatJics
Paul A. Miller, Pediatrics
University of Chicago
Hospi tal
Gregory R. Ci zek,
Radiology - Diagnostic
University of Illinois Hospital
Evan K. Saunders,
Obstetrics & Gynecology
Oak Park
West Suburban Hospital
Center
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Warren K. Slaten,
Transi tional, UMDNJ
New Jersey Medical
School, Physical Mcdicine
Indiana
Bloomington
Indi ana University Medical
Center
Jeffery D. Grill s, Pediatrics
Kentucky
Louisl'ille
Uni versity of Loui sv ille
School of Med icine
Mary R. Morgan, Pediatrics
Kansas
Kansas City
University of Kansas Medical
Center
Gyan S. Brard, Internal
Medicine

Maryland
Baltimore
John Hopkins Hospital
Cristina M. Petit, Obstetrics
& Gyneco logy
Cornelius 1. Clancy, School
of Hygiene and Public
Health, Research-Clinical
Medicine
Sinai Hospital
Benjamin Mov sas, Internal
Medicine Prelimin ary,
Johns Hopkins Hospital,
Radiology - Diagnostic
University of Maryland
Edward D. King, General
Surgery, Urol ogy
Bethesda
Bethesda Naval Hospital
John L. Lindsey,
Transitional

Michigan
Ann Arhor
Un iversity of Michigan
Hospitals
Michael N. Polinsky,
Neuros urgery
Detroit
Wayne State University,
Detroit Medical Center
Dex ter E. Arrington,
Obstetrics & Gynecology
Royal Oak
William Beau mont Hospital
James K. Bischoff, Surgery
Preliminary, Washington
University, Otolaryngology
Ypsilanti
CMHC/St. John 's Merc y
Hospital
Anthony T. Pu, Internal
Medicine Preliminary,
University of Michigan,
Radiation Oncology
Minnesota
M i I1neapolis
Hennepin County Medical
Center
David L. Bowlin , In te rnal
Medi ci ne
Rochester
Mayo Graduate School of
Medicine
Nancy M. Lynch ,
Orthopedic Surgery
Missouri
Columhia
University of Mi ssouri
Hospital

IflI
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Anita J. Holtz, Fam il y
Practice

Sf Louis
Dl:tl coness Hos pital
W illiam S. Anast , Internal
Medicine Preliminary,
Unive rsity of Misso uri ,
Anesthesiology
St. John's Mercy Medical
Center
Shahrdad Khodamoradi,
Transitional, Washin gton
University School of
Medicine, Radiation
O ncology
SI. Mary's Health Center
Christopher D. Ne weJl ,
fnternal Medicine
Pre liminary, Bames
Hospit:.l.l, Anesthesiology

Was hington University
Medical Center
Barnes H ospital
Todd D. Alexander, Surgery
Preliminary
Steven E. Collum ,
Anatomic Pathology
Michael P. Curran,
Orthopedic Surgery
Steven M. Fine, Internal
Medicine
Mitchell A. Fremling ,
General Surgery
Adam J. Gerber, General
Surgery, Wash ington
University, Urology
Christina L. Guyton,
Psychiatry
C uni s R. Hall , Anatomic
Pathology

John O. Krause, Orthopedic
Surgery
John G. Lacy, Anatomic
Pathology
Hamid R . Latifi , Radiology 
Diagnostic
Dean Y Li, Internal
Medicine Preliminary
Robinna Lorenz, Laboratory
Medicine
Brent W. Miller, Internal
Medicine
Linda R. Peterson, Intemal
Medicine
Shawn P. Quillin, Rad iology 
Diagnostic
Mary Beth Scholand ,
[ntemal Medicine
Leland Scott, Internal
Medicine Preliminary,
Johns Hopkins University,
'eu rology

Alistair 1. Scriven , Internal
Medicine
Christopher M . Speidel,
Internal Medicine
Peter G. Van Deerlin,
Obstetrics & Gynecology
Dean H. Weber, General
Surgery
Rebecca S. W olfe r, General
Surgery
Jewish Hospital
Peter L. Apicella, Radi ology
- Diagnostic
William 1. Benevento,
Internal Medicine
Preliminary , Washington
Uni versity, Ophthalmology
Lawrence R. Bro wn,
Internal Medicine
Pau l L. Chesis, Internal
Medicine Preliminary

•
•

•
Nallcy LY1lch alld John Carey.
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Andy C. Dean, Internal
Medicine Preliminary,
Cornell University, New
York Hospital, Neurology
Steven A. Kane, Internal
Medicine Preliminary,
Columbia University/
Harkness Eye Institute,
Ophthalmology
Lyree N. Mikhail, Internal
Medicine Preliminary
Margaret K. Pou los, Internal
Medicine Preliminary,
Washington University
Medical Center,
Ophthalmology
William S. Schwab, Internal
Medicine
SI. Louis Children 's Hospital
Robert O. He uckeroth ,
Pediatrics
Peter S. Keiffer, Pediatrics
Margaret R. Mac Donald ,
Ped iatrics
Arun A. Ran gaswami,
Pediatrics
Randall R. Sercombe,
Pedi atrics
Marianne T. Sweetser,
Pediatrics
Washington Univers ity
Andrew Hing, Postdoctoral
Fellows hip - Che mistry
Albert H. Park, Research 
Otolaryngology
Jonathan Silverstein,
Research - Pharmacology
New Mexico
Alhuquerque
University of New Mexico
School of Medicine
Peter A . Looby, Orthopedi c
Surgery
New York
New York
Ne w York University Medical
Center
David A . Russian, Internal
Medici ne
Presbyterian Hospital
Daniel S. Horwitz,
O rthopedic Surgery
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Marcie and Frank Bellafiore.
Rochester
Strong Memorial Hospital
Brian N. Schwartz, Surgery
Preli minary, Urology
Nor th C arolina
Durham
Duke Unive rsity Medical
Center
William N. Peugh, General
Surgery
Ohio
Cleveland
Cleveland Clinic Foundation
Barry T. Kahn, Surgery
Preliminary
Cincinnati
University of Cincinnati
Hospital
Betty S. McDonald ,
Pediatrics
Dou glas G. Young, Internal
Medicine
Pa ul 1. Eastmann, Family
Practice
Pennsylvania
Philadelphia
Thomas Jeffe rson University
Shih-Wen Hsu, Internal
Medicine
Francis X . Keel ey, Surgery
Preliminary, Urology

Temple University I Ios pital
Philip N. Salen, Internal
Medi ci ne
University of Pennsylv ania
Martin M. Matzuk ,
Pathology & Lab Medi c ine
Pittshurgh
University Health Center
Babu Y. Gupta, Psychiatry
Montefiore Hospital
Darryl L. Hou ston,
Transitional, Alleghen y
General Hospital ,
Anesthesiology
Tennessee
Memphis
Me thodist Hospital
Sann R. Gossum,
Tran sitional, Campbell 's
Clinic, Orthopedic Surgery
Nash ville
Vanderbilt University Medical
Center
Dale S. Horne, Surgery
Pre liminary, Ne urosurgery
Texas
Houstoll
Baylor College of Medicine
John 1. Lee, Internal
Medicine

Utah
Salt Lake City
University of Utah Affiliated
Hospitals
JelUlifer A. DcBlieck,
Internal Medicine
Timothy M . DeBlieck,
Family Practice

Virginia
Charlottesville
University of Virgi nia
Frank 1. BeHafiore,
Patho logy
Roanoke
Roanoke Me morial Hosp itals
Jerome R. Fre und, Family
Practice
Washington
Seattle
University of Was hington
Affiliated Hospita ls
Deborah L. Greenberg,
Internal Medic ine Primary
William T. Dauer, research
in molecular bi ology
Tammy Z. Movsas, research
fellowship
Bradley 1. Snyder, will be
taking a year off to be
President of AMSA

~~IiO/n Curtis, M D
(righl) and
l.emon, M .D. '55. n C.

10k .

A ward winners (seated) Grace Bergner, M.D. '43, Lauren V. Ackerman, M.D., Dorothy Reister, M .n. '50. Standing are Ma urice./. Lonsway, M.D. '50

(left), I. Jerome Fiance, M.D. '35, Purnell W. Choppin, M.D. F.H.5., Robert Paille, M .D. F. II.5. and reollard Jarel/, M .D . '62.

Alumni Achievement
Awards:
Purnell W. Choppin, M.D.,
H.S. '57, president of the
Howard Hughes Medical Insti
tute, is considered by col
leagues to be a "humble, unas
suming" man who is always
willing "to put himself in a
position to help others. " As an
intern and resident in internal
medicine at the School of
Medicine in the early and
mid-1950s, Choppin began
building a highly successful
career as an inv estigator, ad
ministrator, teacher and phy si
cian, first at Rockefe ller Uni
versity and then at the Hughes
Institute. He has established
himself by discovering the
means by which certain vi
ruses , particularly influenza
and measle viruses, penetrate
cells, attack the body defense
mechanisms and multiply,
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research that ultimately
opened up a new field of drug
the rapy. He was eventually
named the Leon Hess Profes
sor of Virology at Rockefeller
in 1980, heading a laboratory
that continues to concentrate
on his initial discoveries. He
has been the recipient of nu
merous honors and awards ,
and has been an adviser to
various govemmental and pri
vate organizations in the fields
of virology, multiple sclerosis,
cancer and research.

Leonard Jarett, M.D., '62.
Leonard Jarett bui It the
School of Medicine's Divi
sion of Laboratory Medicine
into a model for the nation as
its first head in 1969, and, in
the early ' 80s, built the Depart
ment of Pathology and Labo
ratory Medicine at the Uni
versity of Pennsylvania into
one of the top three such
departments in the nation. As

a researcher Jarett has con
centrated in the field of insulin
action , where he has made
several major technological
advances and seminal sc ien
tific observations that ha ve
opened new areas of resea rch.
He has had more than 129
original papers, 23 books or
book chapters and Ino ab
stracts published . And as a
professor, he has trained more
than 30 individuals who are
now chairmen of departments,
division heads or faculty mem
bers at academic institutions
throughout the world.

Dorothy D. Reister, M.D.,
'50, has fought long and hard
for a variety of worthy medi
cal causes for children and
battled to help women become
leaders in medicine . The long
time Kansas City pediatrician
received her medical degree
in 1950 and, following a year's
internship at Hahnemann Hos

pital in Philadelphi a, retumed
to SI. Louis as a resident in
pediatrics at St. Loui s Chil
dren 's Hospital. She joined
Well Baby Clinics in SI. Louis
County and became an in
structor in pediatrics at Wash
ington University in 1953 ,
before moving pennanently to
Kansas City in 1955. She has
been in private practice si nce
1956. She was the first woman
president of the Jackson Coun
ty (Missouri) Medical Society,
which is now the Metropolitan
Medical Society of Greater
Kansas City, and will become
the first woman president of
the Mi ssouri State Medical
Association , afte r previously
serving as that organization 's
first woman council represen
tative and council c hainnan .
In addition to serving on the
boards of several organiza
tions , she is past president of
the AmeJican Medical Wom

en's Association and has been
a member of the American
Medical Association and the
Greater Kansas City Pediatric
Society.

Alumni/Faculty Awards
When colleagues speak of
Grace E. Bergner, M.D., '43,
they not only talk of her pro
fessional and academic ac u
men, they also say: "She was
loved by all he r patients and
staff as though she were part
of their families." "She has
given more time caring for
others than one can imagine."
"Compassionate and caring.
Her untiring effo rts were evi
dence of her dedication to the
field of medicine." Following
her graduation from the
School of Medicine, she was
an intern at Barnes Hospital
before becoming an assistant
resident there. In 1944, she
went to Yale New Haven Hos
pital as an assistant resident
before moving to Harvard
Medical School where she was
the Commonwealth Fund Re
search Fellow in Metabolic
Diseases. She returned to St.
Louis in 1947 as a partne r in
Grant Medical Clinic, ulti
mately staying there for 40
years. She served on the staffs
of Barnes Hospital, Missouri
Baptist Hospital, and St. Luke's
Hospital in St. Louis. Her aca
demic career began in 1948 as
an instructor in clinical medi
cine at the School of Medicine,
and she became an emelitus
associate professor of clinical
medicine in 1987.
For more than half a century,
I. Jerome Fiance, M.D., '35,
has devoted himself 10 the St.
Loui s community and to the
School of Medicine. As one
colleague put it, " He has

served as a role model for gen
erations of physicians,"
through hi s varied roles as an
extraordinary teacher, research
er, clinician and civic leader.
After graduating from the
School of Medicine in 1935,
with an internship and resi
dency at Jewish Hospital,
Rance moved on 10 become a
resident at Robe l1 Koch Hos
pital , which was then the SI.
Louis City Tuberculosis Hos
pital. After three years there,
Fiance relocated to New York
in 1940 as a res ident in the
Pneumonia Service at Harlem
Hospital. After returning to
SI. Louis, he joined the
School's clinical faculty, was
named director of the Wash
ington University Pulmonary
Service at SI. Loui s City Hos
pital, and also became a Pul
monary Consu ltant to Barnes
and Jewish Hospitals. In 1953,
he helped initiate the Home
Care Program at Jewi sh Hos
pital , serving as its director for
II years, during which time
he instituted a home care pro
gram fo r tuberculosi s patients.
It was the first such formal
program in the United States
and has subsequently served
as a model for others. On
Fiance 's 65th birthday in
1976, friends and patients
establi shed the 1. Jerome
Fiance Visiting Professorship
in his honor.
Maurice J. Lonsway Jr.,
M.D., '50, is an outstanding
pediatrician and leader in the
medical communily. Follow
ing an internship at St. Louis
City Hospital and residency in
pediatlics at St. Loui s Chil
dren 's Hospital , Lonsway
wen I to Boston as a fellow at
C hildren's Hospital. He
returned to SI. Louis that
same year as an instlllctor in
clinical pediatrics at Washing
ton University and joined the

slaffs of SI. Louis Children's
Hospital and SI. Luke 's Hos
pita.!. He joined the staff of SI.
John 's in 1956. With the help
of his father, Maurice Lonsway
Sr., M.D. , he aided in the for
mation of the Children's Clin
ic , which resulted in a very
active pediatric unit at Chil
dren 's Hospital and Washing
ton University. He has been an
influential leader at Children's,
serving as pres ident of the
Medical Staff twice. A full
professor of clinical pediatrics
si nce 1980, he is known for
hi s personal attention to stu
dents and residents. He is a
member of the Admi ssion s
Committee of the School and
was clinical representative to
the School of Medicine Exec
utive Faculty from 1977-1981
and in 1974 was president of
the St. Louis Pediatrics Society.
For over three decades,
Robert Paine, M.D., has con
sistently been a favorite of
medical students. A three-time
Teacher of the Year Award
winner, he is also a valued
member of the Department of
Medic ine. A 1944 graduate of
Harvard Medical School, he
was an intern and resident at
Barnes Hospital before join
ing the AiJ Force in 1946.
Following his military ser
vice, he returned to the School
of Medicine as a Rockefeller
Fellow in Medicine. He was
named chief of the Depart
ment of Medicine and also
appointed to the ne wly created
position of coordinator of
medical education at SI.
Luke 's Hospilal in 1963. He
served in those positions until
last year, stepping down to
concentrate his efforts as di
rector of St. Luke's Heart
fnstitute in cardiology, a field
in which he is considered an
expert. He is a professor of
clinical medicine at th e School

of Medicine, a posi tion that
he has held since 1972.

Distinguished Service
Award
Lauren V. Ackerman,
M.D., is a medical pioneer,
author, influential teacher, and
an authority in surgical pathol
ogy. A 1932 graduate of the
University of Rochester Med
ical School, Ackerman in
terned at the University of
California at San Franci sco
(UCSF) before completing
residencies in tuberculosi s,
medicine and pathology in
California and Massachusetts.
In 1939, he became an instruc
tor of medicine and pathology
at UCSF before joining Ellis
Fische l State Cancer Hospital
in Columbia, Missouri, as a
pathologi st and medical direc- .
tor for the nex t year. fn 1942,
Dr. Ackerman joined the fac
ulty of the School of Medi
cine as an assistant professor
of pathology while still work
in g in Columbia. He is recog
nized for training an entire
generation of surgical pathol 
ogists , many of whom are
professors and directors of
prog rams across the country,
as well as for making Wash
ington University Medical
Cente r the pre-eminent center
in the world in which to train
in surgical pathology. In addi
tion, he is the au thor of "Sur
gical PathOlogy," which is
now in its seventh edition.
The author of more than 185
publication s, Dr. Ackerman is
a highly respected consultant
and lecturer. He holds
innumerable national and
international honors for his
contributions to pathology as
well as to cancer research.
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Roger L. Mell, M.D. '65 (right), president ofthe
Washington University Medical Center Alumni
A ssociation passes tile gavel to iI/coming presi·
dent losep" F. Ru witch ] r. , M.D . '66.

W. Grant Stevens.
MJJ. '80, (left) • Bert
Ma ndelba um , M .D,
'80 and Bill M organ ,
/11.0 . '80.

Everett lung, M. D.
'55 (left) with friellds.

William Shaw, M.D.

Scienfijic program
speaker Irving
SelikofJ, M.D.

Attendees danced 10
Ihe music oj l" e Hoi
Docs.

Mrs. A. No rman
Arneson (f/lcing
camera) hugs
Mrs . ./. Ted Jean.

Roberl A. O' Dell,
M.D . '55 (Iejl), Jules
Ke rnan, M.D. '55,
Wayne Buck, M.D .
'55 and Mrs. B uck
greel Charlie
Ruggieri.
David Go/tfring, M.D. '40 (rigll l) wilh Llewellyn Sale Jr. , M.D. '.lO.

Chancellor William
H. Danforth, M.D.
(lefl) and Leonard
Jaretl, M.D. '62.

Mildred Troller,
Ph.D. and Joseph
[wano, M.D. '50.
James Mann, M.D.
'40 (lefl) and William
Read, M.D. '40.

Class of 1950.

Miles Wh itener, M.D.
'55 (left), Fred
Krause, M.D. '55
alld Robert Drews,
M.D. '55.

Roger Fuller, M.D .
'50 and friends.

William A. Peck,
M.D., vice chancellor
for medical affairs
and dean (right) with
William Berman,
M.D. '35 and AI/n
Henrichs, M.D. '50.

Irving SelikofJ, M.D.
(left) and Richard
Sutter, M.D. '35.

Ann Henrichs, M.D.
'50, Shields Livingston,
M.D. '50, Wesley
Gabrio, M.D. '50 and
f1arriett Livillgston,
M ./). '50.

Everett jung, M.D.
'55 (facing camera)
with friends.

Mrs. Richard H. Mcilroy (left), Richard II.
McIlroy, M.D. '35, V. Terrell DaYis, M.D. '36,
E velyn Jvey-Davis and Leo Sachar, M.D. '35.

john Skinner, M.D.
'40 and William Read,
M.D. '40.

Edward Emura, M.D.
'50 greeting friends.

Mrs. Edward Emura
(right) with Dr. and
Mrs. John C. Herweg.

Roger Fuller, M.D.
'50 and Edward
Emura, M.D. '50.

Dorothy Reister, M.D .
'50, W. Spencer Payne,
M.D. '50 and M.
John Epp, M.D. '50.
Dean's luncheon,
Olin residence hall.
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Washington University Medical Center.
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This spring's graduates of the School of Medicine included 92 recipi
ents of the M.D. degree, 19 of the M.D'/Ph.D. and 2 of the M.A.lM.D.
The School also awarded 27 degrees in health administration, 39 in
physical therapy and 36 in occupational therapy.

